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Introduction {#sec1}
============

Murine embryonic stem cells (ESCs) are self-renewing, pluripotent cells able to differentiate into cells of all three germ layers. Pluripotency and self-renewal are maintained primarily by the core transcriptional factors Nanog, Oct4, and Sox2 ([@bib11]) but require both the cooperation of other factors and coregulators ([@bib16]) and an efficient telomere maintenance mechanism ([@bib12]). In mammals, telomere maintenance is achieved via a telomerase reverse transcriptase (*Tert*) and an integral RNA component (*Terc*) that synthesize new telomeric DNA during cell proliferation. An appropriate telomere maintenance system is important for ESC replicative potential ([@bib1]; [@bib2]; [@bib21]). During the reprogramming of differentiated cells into stem cells, an increase in telomerase activity leads to telomere elongation and the acquisition of epigenetic marks characteristic of longer telomeres ([@bib21]). Notably, the teratoma-forming ability of ESCs derived from late generation (G3--G4) *Terc*^*−/−*^ mice with critically short telomeres is greatly reduced ([@bib12]).

Results {#sec2}
=======

Critically Short Telomeres in ESCs Lead to Elevated Basal Levels of Nanog {#sec2.1}
-------------------------------------------------------------------------

We sought to address the impact of telomere dysfunction not only upon the capacity for cell differentiation but also upon the maintenance of a differentiated state. Late-passage *Tert*^−/−^ ESCs (*Tert*^−/−S^) ([@bib18]) that possessed shorter telomeres and a significant accumulation of telomere signal-free ends relative to wild-type (WT) ESCs or *Tert*^−/−^ cells at earlier passages (*Tert*^−/−L^) ([Figures S1](#app2){ref-type="sec"}A--S1C available online; p \< 0.0001; Fisher's exact test) were nonetheless proliferation-competent and did not exhibit an altered doubling time, cell morphology, or cell-cycle distribution ([Figures S1](#app2){ref-type="sec"}D and S1E; data not shown). However, *Nanog* messenger RNA (mRNA) and protein levels were significantly elevated ([Figures 1](#fig1){ref-type="fig"}A--1C and [S1](#app2){ref-type="sec"}F--S1G). No difference was observed in *Oct4*, *Sox2*, and *Klf4* expression ([Figures 1](#fig1){ref-type="fig"}C and [S1](#app2){ref-type="sec"}F). To test whether the difference in Nanog expression was related to telomere dysfunction, we reintroduced WT *Tert* into late-passage *Tert*^−/−^ ESCs (*Tert*^−/−R^), and, after the propagation of clonal lines expressing *Tert*, we observed the reparation of telomere signal-free ends and a restoration of Nanog levels closer to the levels observed in WT ESCs and *Tert*^−/−^ ESCs at early passage ([Figures 1](#fig1){ref-type="fig"}A--1D, [S1](#app2){ref-type="sec"}A--S1C, S1F, and S1G). Transient expression of *Tert* for 72 hr, a period of time insufficient to permit telomere extension, failed to restore Nanog to levels comparable to WT ESCs (data not shown). These data suggest that the dysregulation of Nanog in *Tert*^−/−S^ ESCs is a consequence of critically short telomeres.

ESCs that express high levels of Nanog tend to self-renew, whereas cells that express low levels of this factor tend to differentiate ([@bib6]; [@bib26]; [@bib29]). Immunofluorescence analysis of *Tert*^−/−S^ ESCs cultured on gelatin in leukemia inhibitory factor (LIF)-containing media revealed a significant increase in the percentage of Nanog^high^ cells in comparison to WT and *Tert*^−/−R^ ESCs ([Figures 1](#fig1){ref-type="fig"}A and [S1](#app2){ref-type="sec"}G) ([@bib26]). We confirmed elevated Nanog expression in *Tert*^−/−S^ ESCs via fluorescence-activated cell sorting (FACS) analysis ([Figure 1](#fig1){ref-type="fig"}B). We also measured the expression of other factors involved in the pluripotency regulatory network (*Rex1*, *Esrrb*, and *Tbx3*) ([@bib9]; [@bib13]; [@bib28]), including pluripotency factors that negatively regulate Nanog expression (*Zfp281*) ([@bib10]) and lineage differentiation markers (*Cdx2*) and the endoderm markers (*Gata6* and *Gata4*) that are negatively regulated by Nanog ([@bib29]). As anticipated, *Rex1*, *Esrrb*, and *Tbx3* mRNA levels were increased in *Tert*^−/−S^ ESCs, whereas *Zpf281* and *Cdx2* levels were unaffected ([Figure 1](#fig1){ref-type="fig"}C). However, *Gata6* and *Gata4* were also increased ([Figure 1](#fig1){ref-type="fig"}C). Consistent with these observations, chromatin immunoprecipitation (ChIP) analysis revealed lower levels of Nanog occupancy on the *Gata6* promoter ([Figure S1](#app2){ref-type="sec"}I). Nevertheless, the recruitment of Nanog to its own promoter, which represses its own expression ([@bib10]), increased in *Tert*^−/−S^ ESCs ([Figure S1](#app2){ref-type="sec"}I). Thus, the increased expression of *Nanog* is not a consequence of the impaired occupancy of Nanog on its own promoter.

Perturbations in H3K27me3 Are Associated with Critically Short Telomeres {#sec2.2}
------------------------------------------------------------------------

Telomere attrition is associated with the loss of certain heterochromatin markers and DNA hypomethylation at telomeric and subtelomeric regions ([@bib3]). We postulated that the increase in *Nanog* expression could be linked to a general dysregulation of epigenetic repression, given that low levels of trimethylation on histone H3 lysine 27 (H3K27me3) promote *Nanog* and *Gata6* expression ([@bib19]; [@bib27]; [@bib33]). H3K27me3 was reduced at *Nanog* and *Gata6* promoters in *Tert*^−/−S^ ESCs, whereas H3K4me3 levels at the *Nanog* promoter were unaffected ([Figure 1](#fig1){ref-type="fig"}E). H3K27me3 and H3K4me3 enrichment on the *Oct4* promoter was unaffected ([Figure 1](#fig1){ref-type="fig"}E). These perturbations, including a slightly increased level of global H3K27me3 in *Tert*^*−/−*S^ ESCs, were restored upon telomere elongation ([Figures 1](#fig1){ref-type="fig"}E and [S1](#app2){ref-type="sec"}H). These changes were not accompanied by a significant alteration in the three-dimensional localization of telomere DNA or chromatin in interphase nuclei ([Figure S1](#app2){ref-type="sec"}J). Thus, the altered expression of *Nanog* and *Gata6* reflects changes in heterochromatin at their respective promoters independent of Nanog occupancy. Moreover, these results demonstrate that critically short telomeres also affect chromatin organization at loci distal to telomeres.

Critically Short Telomeres Perturb the Ability of ESCs to Remain Stably Differentiated {#sec2.3}
--------------------------------------------------------------------------------------

The impact of Nanog misregulation upon differentiation was tested by treating ESCs with 5 μM all-*trans* retinoic acid (ATRA), which was followed by the removal of ATRA and the readdition of LIF-containing media ([Figure 2](#fig2){ref-type="fig"}). Although longer ATRA treatment times were required to achieve suppression of *Oct4*, *Nanog*, and *Sox*2 mRNA and protein to levels comparable to WT or *Tert*^*−/−*^ ESCs with longer telomeres ([Figures 2](#fig2){ref-type="fig"}A−2D and [S2](#app2){ref-type="sec"}), *Tert*^−/−S^ ESCs nevertheless exhibited a low proliferative capacity after ATRA treatment, which was consistent with a differentiated state ([Figure 2](#fig2){ref-type="fig"}E). However, after the readdition of LIF-containing media, *Tert*^*−/−*S^ ESCs failed to maintain repression of Nanog and exhibited robust colony formation only 6 days after the readdition of LIF-containing media ([Figures 2](#fig2){ref-type="fig"} and [S2](#app2){ref-type="sec"}). As an independent marker of differentiation, WT and *Tert*^*−/−*S^ cells were transduced with an *Oct4* promoter-driven green fluorescent protein (GFP) construct, treated with ATRA for 12 days, and then sorted to allow the selection of the GFP-negative population by FACS. Sorted GFP-negative cells were plated in the presence of LIF-containing media for 10 days, followed by an assessment of the percentage of GFP-positive cells. *Tert*^*−/−*S^ cells exhibited a high percentage of GFP-positive cells after the readdition of LIF-containing media ([Figure 2](#fig2){ref-type="fig"}F). These results demonstrate that ESCs with telomere dysfunction were able to execute only an incomplete, transitory repression of pluripotency genes in response to differentiation cues.

ESCs with Short Telomeres Exhibit DNA Hypomethylation {#sec2.4}
-----------------------------------------------------

Critically short telomeres are associated with DNA hypomethylation at subtelomeric DNA ([@bib3]). Given that we observed chromatin alterations at loci distal to telomeres, we tested whether *Tert*^−/−S^ ESCs also exhibited altered DNA methylation throughout the genome. Bisulphite-sequencing analysis of the *Nanog* and *Oct*4 promoters revealed a significant reduction in the acquisition of methylated cytosine in *Tert*^−/−S^ ESCs treated with ATRA relative to WT or *Tert*^−/−R^ ESCs (p ≤ 0.01 and p \< 0.0001, respectively; Fisher's exact test) ([Figure 3](#fig3){ref-type="fig"}A). Furthermore, *Tert*^−/−S^ ESCs failed to maintain even this level of cytosine methylation after the readdition of the LIF-containing media (p \< 0.0001 and p = 0.03, respectively). At both promoters, this impairment was rescued in *Tert*^−/−R^ ESCs (p \> 0.05; [Figure 3](#fig3){ref-type="fig"}A). Genome-wide methylation measured by an ELISA-based detection system against methylcytosine was also significantly reduced in *Tert*^−/−S^ ESCs ([Figure 3](#fig3){ref-type="fig"}B). Nonspecific epigenetic drift appeared improbable, given that WT and *Tert*^−/−R^ ESCs did not exhibit these changes after a similar propagation period. Although ESCs can tolerate DNA hypomethylation without impairment of cell proliferation ([@bib31]), hypomethylation nonetheless impairs the capability of ESCs to achieve, and maintain a differentiated state ([@bib8]; [@bib14]; [@bib30]). Thus, DNA hypomethylation in *Tert*^−/−S^ ESCs arose in response to critically short telomeres and impeded their stable differentiation.

Restoration of Dnmt3b or Depletion of Nanog Rescue the Stable Differentiation of ESCs with Short Telomeres {#sec2.5}
----------------------------------------------------------------------------------------------------------

We tested whether the restoration of DNA methylation might restore the differentiation capability of *Tert*^−/−S^ ESCs. In mammals, genomic DNA methylation is principally regulated by three DNA methyltransferases (Dnmts): Dnmt1 (methylation maintenance) and the de novo methyltransferases Dnmt3a and Dnmt3b ([@bib17]; [@bib24]). Although Dnmt1 expression was unaffected in *Tert*^−/−S^ ESCs, the expression of de novo methylases was reduced ([Figure 3](#fig3){ref-type="fig"}C). Enforced expression of Dnmt3b in *Tert*^−/−S^ ESCs restored repression of Nanog ([Figures 3](#fig3){ref-type="fig"}D, 3E, and [S3](#app2){ref-type="sec"}(A) and restored the repression of *Nanog*, *Oct4*, and *Sox2* mRNA upon ATRA treatment ([Figures 4](#fig4){ref-type="fig"}A and 4B). Dnmt3b expression also led to a significant reduction in the colony formation of *Tert*^−/−S^ ESCs after the readdition of LIF-containing media ([Figure 4](#fig4){ref-type="fig"}C). The level of H3K27me3 at the *Nanog* promoter was also partially rescued in *Tert*^−/−S^ ESCs that expressed elevated Dnmt3b ([Figure 4](#fig4){ref-type="fig"}D). Consistent with a direct role of Nanog suppression in the maintenance of stable differentiation, Nanog depletion by small hairpin RNA (shRNA) was sufficient to overcome the inability of *Tert*^−/−S^ ESCs to remain differentiated ([Figure 4](#fig4){ref-type="fig"}C), and all genotypes transduced with *Nanog* shRNA exhibited a decrease in pluripotency gene expression ([Figure S4](#app2){ref-type="sec"}). These results demonstrate that the mechanism of impaired ability to maintain stable differentiation in *Tert*^−/−S^ ESCs acts via the perturbation of de novo DNA methylation, which, in turn, influences chromatin organization and the ability to repress pluripotency factors such as *Nanog* under differentiation conditions.

Discussion {#sec3}
==========

Here, we report that critically short telomeres led to genome-wide DNA hypomethylation and that changes in H3K27 trimethylation occurred at loci distal to telomeres. The trimethylation of H3K27 is mediated by the polycomb repressive complex 2 (PRC2) and is associated with ESC identity ([@bib27]). H3K27me3 is one of the principal histone repression markers, and its diminished enrichment on *Nanog* and *Gata6* promoters has been linked to the upregulation of these genes ([@bib15]; [@bib19]; [@bib27]; [@bib33]). Although the global level of H3K27me3 increased in *Tert*^*−/−*S^ ESCs similar to recent studies that associate H3K27me3 enrichment with unmethylated CpG islands, its presence at *Nanog* and *Gata6* promoters was reduced ([@bib20]; [@bib22]). These data support the observation that DNA hypomethylation leads to overall increased levels of H3K27me3 in normally methylated regions but decreased levels of H3K27me3 in ordinarily unmethylated regions ([@bib5]). Our data suggest a model whereby telomere-shortening-induced de novo Dnmt downregulation leads to DNA hypomethylation and altered H3K27me3 enrichment at promoters, which, in turn, affects the ability to repress pluripotency factors critical to stable differentiation in ESCs ([Figure 4](#fig4){ref-type="fig"}E).

The regulation of factors that affect pluripotency and differentiation are important not only to development but also to disease. For example, pluripotency factors such as Nanog tend to be highly expressed in undifferentiated tumors and in putative cancer stem cells ([@bib32]). In addition, some cancer therapies employ differentiation-inducing agents such as retinoic acid in the treatment of acute promyelocytic leukemia ([@bib25]). Thus, it will be important to test whether critically short telomeres also influence cell fate in human cancer cells, particularly in the case of telomerase-inhibition strategies designed to instigate telomere instability.

Experimental Procedures {#sec4}
=======================

Cell Culture and Transfection {#sec4.1}
-----------------------------

All experiments employed two separately generated ESC lines containing a disruption of endogenous *Tert*, as previously described ([@bib18]). ESC lines were cultured on gelatin-covered dishes and maintained in Glasgow's Modified Eagle's Medium (GMEM; GIBCO) supplemented with 15% v/v fetal bovine serum (FBS), 0.055 mM β-mercaptoethanol (Sigma-Aldrich), 2 mM L-glutamine, 0.1 mM GMEM nonessential amino acids, 5,000 units/ml penicillin and streptomycin, 1,000 units/ml of recombinant LIF (Chemicon), and 1 μg/ml doxycycline and maintained at 37°C with 5% v/v CO~2~. To restore *Tert* expression to *Tert*^−/−S^ ESCs cells at passage, we cotransfected 70, ESCs with pTRE-Bi-*Tert*-IRES-EGFP-Hygro (or a similar vector lacking *Tert*) and CAG-rtTA advanced (pTET-ON advanced vector; Clontech). For constitutive expression of *Tert*, *Tert*^−/−S^ ESCs were transfected with CAG-*mTert*-IRES-Puro or CAG-IRES-Puro. For expression of Dnmt3b, *Tert*^−/−S^ ESCs were transfected with CAG-*Dnmt3b*-IRES-Puro or CAG-IRES-Puro. All transfections employed Fugene 6 (Roche) in a 3:1 ratio to DNA according to the manufacturer's instructions. For *Tert* rescue or *Dnmt3b* reintroduction, cells were propagated for four passages under selection with hygromycin (500 μg/ml) or puromycin (5 μg/ml), and individual colonies were isolated. For *Nanog* shRNA transduction, cells were infected with commercially available lentiviral particles (Santa Cruz Biotechnology) and selected with puromycin (5 μg/ml). Cell transduction with *Oct4*-promoter GFP was performed by infection with commercially available lentiviral particles (System Biosciences). All lentiviral infections were performed in the presence of Polybrene (5 μg/ml; Santa Cruz Biotechnology). All experiments were performed with more than one clonal isolate.

Differentiation Assay {#sec4.2}
---------------------

Cell populations of the indicated genotype (1 × 10^5^) were plated in non-gelatin-covered dishes in LIF-free media containing 5 μM ATRA (Sigma-Aldrich) for the indicated amount of time with ATRA-media replaced every 3 days. At the indicated time point, cells were replated in gelatin-covered dishes with LIF-containing media. For the single colony formation assay, a set of serial dilutions was performed, and the number of viable ES cell colonies was assessed with alkaline phosphatase (Millipore).

Quantitative Fluorescence In Situ Hybridization {#sec4.3}
-----------------------------------------------

The quantitative fluorescence in situ hybridization (Q-FISH) protocol was carried out as described previously ([@bib18]). Metaphase spreads were captured with the use of Metafer 4 software and analyzed with Isis software. Statistical analysis of telomere intensity distribution was performed with Welch's unpaired t test. The incidence of telomere signal-free ends was defined as the number of chromosome ends possessing a telomere signal (in arbitrary units) between 0 and 600, and statistical significance was assessed with Fisher's exact test (InStat 3, GraphPad).

qRT-PCR {#sec4.4}
-------

Total RNA was isolated from cells with the use of Triazol (Invitrogen) according to the manufacturer's instructions. Reverse transcription was carried out with the use of 0.5 μg of template RNA, random hexamer primers, and smart MMLV reverse transcriptase (Clontech). Diluted complementary DNA (20×) was subjected to real-time PCR analysis using a SYBR Green Master Mix (Roche) on a LightCycler 480 system (Roche). Background values (no reverse transcriptase added) were subtracted and values were normalized to *glyceraldehyde 3-phosphate dehydrogenase* (*GAPDH*) (n \> 3). The oligos employed are listed in [Table S1](#app2){ref-type="sec"}. Statistical analysis was performed by ANOVA and a related Dunnett's test comparing every group with WT values.

ChIP Sequencing {#sec4.5}
---------------

ChIP experiments were performed as described in [@bib4], except phenol-chloroform was replaced with a Chelex, 100-based DNA isolation method described in [@bib23]. Recovered DNA was analyzed by qRT-PCR as described above. For each pair of primers, triplicate measurements were taken and normalized to input DNA and the amount of DNA recovered from the *GAPDH* promoter (n \> 3). Antibodies employed were as follows: rabbit anti-Nanog (Bethyl Laboratories); mouse anti-H3K27me3 and anti-H3K4me3 (Abcam); and murine IgG (Sigma-Aldrich). Oligos employed are listed in [Table S1](#app2){ref-type="sec"}. Statistical analysis was performed by ANOVA and a related Dunnett's test comparing every group with WT values. In each experiment, the signal present after immunoprecipitation with IgG was defined as background and subtracted prior to normalization to input DNA and *GAPDH*.

Methylation Assay {#sec4.6}
-----------------

Relative genomic DNA methylation was assessed with the use of the ELISA-based Imprint Methylated DNA Quantification kit (Sigma-Aldrich) according to the manufacturer\'s instructions, with the use of 100 ng of genomic DNA per sample (n \> 3).

Bisulphite Sequencing Analysis {#sec4.7}
------------------------------

DNA bisulphite conversion was performed as described previously ([@bib7]). After bisulphite conversion of unmethylated cytosines to uracil, samples were resuspended in 1 × Tris--EDTA for PCR amplification. PCR products were cloned into pcDNA3.1 Directional TOPO Expression (Invitrogen) vector and colony PCR was performed. Clones (at least ten per sample) of the correct molecular mass were sequenced, and results were analyzed with BiQ Analyzer (<http://biq-analyzer.bioinf.mpi-inf.mpg.de>). Primers employed are listed in [Table S1](#app2){ref-type="sec"}. Statistical analysis of samples employed Fisher's exact test (two-sided) using GraphPad InStat3 ([www.graphpad.com](http://www.graphpad.com)).

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S4, and Table S1
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Supplemental Information contains Supplemental Experimental Procedures, four figures, and one table and can be found with this article online at [http://dx.doi.org/10.1016/j.stem.2013.01.018](10.1016/j.stem.2013.01.018).

![Analysis of Pluripotency Factors in WT and *Tert*^−/−^ ESCs\
(A) Quantification of Nanog levels normalized over DAPI (see [Figure S1](#app2){ref-type="sec"}G for corresponding immunofluorescence images). Note a significant shift (p \< 0.0001) from Nanog-low (DAPI to Nanog-488 ≥ 1.8) to Nanog-high (DAPI to Nanog-488 \< 1.5) cells in *Tert*^−/−S^ in comparison to WT and *Tert*^−/−R^ ESCs (n ≥ 100 per cell population).\
(B) FACS analysis of the Nanog expression profile in the same genotypes as in (A). Note the rightward shift and increase in average Nanog signal intensity in *Tert*^−/−S^ ESCs.\
(C) Relative gene expression analyzed by qRT-PCR, normalized to *GAPDH* (n = 4). Data are represented as mean ± SD.\
(D) (Top) Nanog protein expression with LI-COR quantification below (n = 3). Data are represented as mean ± SD; L, long telomeres (passage 30); S, short telomeres (passage 70); R, *Tert* rescue (70 passages, followed by clonal selection and an additional 4 passages after *Tert* reintroduction). The superscripts 1 and 2 indicate two independently generated *Tert*^−/−R^ colonies.\
(E) ChIP analysis using an antibody to H3K27me3 and H3K4me3. Relative enrichment was quantified with the use of region-specific qPCR primers for *Nanog*, *Oct4*, and *Gata6* promoters. Generic IgG was used as a control (n = 3). Data are represented as mean ± SD. ^∗^, p \< 0.05; ^∗∗^, p \< 0.01; ^∗∗∗^, p \< 0.0001.\
See also [Figure S1](#app2){ref-type="sec"} and [Table S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Differentiation Analysis of *Tert*^−/−^ ESCs\
(A) Bright field images of ESC populations at day 0 and day 6 in media containing 5 μM all-*trans* retinoic acid (ATRA) and, after ATRA removal, an additional 6 days in LIF-containing media. The micrograph bar indicates 200 μm for bright field images and15 μm for immunofluorescence images.\
(B) Nanog immunofluorescence analysis (green, Nanog; red, Actin).\
(C) Nanog protein detection by western blot. Tub, β-tubulin (n = 3).\
(D) qRT-PCR analysis of pluripotency genes after ATRA-induced differentiation. Gene expression at day 0 was arbitrarily set as 100, and the expression through the time course was normalized to mRNA levels at day 0. Values were expressed as a ratio to *GAPDH*.\
(E) Single-colony formation assay after ATRA treatment (6 days) is shown, and, where indicated, the readdition of LIF-containing media (6 days) (n = 3) is shown. The difference in the incidence of colony formation between *Tert*^−/−S^ (after LIF readdition) and all the other genotypes (or *Tert*^−/−S^ without LIF) was statistically significant (p \< 0.0001; ANOVA and related Dunnett's test comparing every group with *Tert*^−/−S^ values). The y axis indicates colony number. Data are represented as mean ± SD.\
(F) *Oct4*-promoter-driven GFP expression analysis of WT and *Tert*^*−/−S*^ ESCs post-ATRA treatment and after cell sorting for GFP-negative cells. The y axis indicates the percentage of GFP-positive WT, or *Tert*^−*/*−^ cells after 12 days of ATRA treatment and FACS sorting (FACS; columns 1 and 3) and after the readdition of LIF-containing media to GFP-negative sorted cells (columns 2 and 4). The difference in the incidence of GFP-positive cells between *Tert*^−/−S^ and WT cells was statistically significant (p \< 0.00001; Welch's unpaired t test). Data are represented as mean ± SD.\
See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![Expression of DNA Methyltransferases in ESCs Lacking *Tert*\
(A) CpG methylation analysis of the *Oct4* and *Nanog* promoters during ATRA treatment, followed by culture in LIF-containing media. Each column represents CpGs in a sequenced clone. Full dots symbolize methylated CpGs, and empty dots symbolize unmethylated CpGs. Percentage values indicate the proportion of methylated cytosine relative to total cytosine residues (n = 10).\
(B) Relative quantification of global DNA methylation (n = 3) is shown. Data are represented as mean ± SD.\
(C) Relative gene expression of *Dnmt1*, *Dnmt3b*, and *Dnmt3a2* analyzed by qRT-PCR. Values were normalized to *GAPDH* (n = 4). Data are represented as mean ± SD.\
(D) (Top) Dnmt3b protein detection by western blot and (bottom) after LI-COR quantification (n = 3). Data are represented as mean ± SD.\
(E) Nanog protein detection by western blot. Tub, β-tubulin (n = 5); R, *Tert* rescue; 3b, *Dnmt3b* rescue. Passage numbers are as in [Figure 1](#fig1){ref-type="fig"}. ^∗^, p \< 0.05; ^∗∗^, p \< 0.01; ^∗∗∗^, p \< 0.0001.\
See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![Differentiation Ability of *Tert*^−/−^ ESCs after Enforced Expression of Dnmt3b\
(A) Nanog protein detection by western blot. Tub, β-tubulin (n = 3). The first two panels on the left are reproduced from [Figure 2](#fig2){ref-type="fig"}C.\
(B) qRT-PCR analysis of pluripotency genes upon ATRA-induced differentiation. Gene expression at day 0 was arbitrarily set as 100 and the expression through the time course was normalized to mRNA levels at day 0. Values were expressed as a ratio to GAPDH. The first two genotypes were reproduced from [Figure 2](#fig2){ref-type="fig"}D.\
(C) Single-colony formation assay after the removal of ATRA and the readdition of LIF-containing media (n = 3). The difference in the incidence of colony formation between *Tert*^−/−S^ and all the other genotypes, apart from short hairpin control-transduced *Tert*^−/−s^ cells, was statistically significant (p \< 0.0001; ANOVA and related Dunnett's test comparing every group with *Tert*^−/−S^ values). The y axis indicates colony number. Data are represented as mean ± SD.\
(D) Chromatin immunoprecipitation analysis of H3K27me3 enrichment at the *Nanog* promoter, as described in [Supplemental Experimental Procedures](#app2){ref-type="sec"}. Data are represented as mean ± SD (n = 3). ^∗^, p \< 0.05; ^∗∗^, p \< 0.01; ^∗∗∗^, p \< 0.0001.\
(E) A schematic showing that telomere shortening impairs the expression of Dnmt3 isoforms, leading to genome-wide DNA hypomethylation, which, in turn, affects H3K27me3 enrichment on specific loci (e.g., *Nanog*), thus impairing the ability of ESCs to sustain pluripotency factor repression after differentiation and growth restimulation.\
See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}
